We serve Chemical Name:N-Methyl-1-(pyrazin-2-yl)methanamine CAS:120739-79-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:N-Methyl-1-(pyrazin-2-yl)methanamine
CAS.NO:120739-79-9
Synonyms:N-Methyl-1-(2-pyrazinyl)methanamine;Methyl-pyrazin-2-ylmethyl-amine;2-Pyrazinemethanamine, N-methyl-;2-Pyrazinemethanamine,N-methyl;N-Methylpyrazinemethanamine
Molecular Formula:C6H9N3
Molecular Weight:123.156
HS Code:2933990090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:190.5±25.0 °C at 760 mmHg
Density:1.0±0.1 g/cm3
Index of Refraction:1.517
PSA:37.81000
Exact Mass:123.079643
LogP:-0.98
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like N-Methyl-1-(2-pyrazinyl)methanamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N-Methylpyrazinemethanamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N-Methylpyrazinemethanamine Use and application,Methyl-pyrazin-2-ylmethyl-amine technical grade,usp/ep/jp grade.
Related News: Today, Novavax is one step closer to addressing the critical and persistent global public health need for additional COVID-19 vaccines,” Novavax president and CEO Stanley Erck said in a statement. “These clinical results reinforce that [the vaccine] is extremely effective and offers complete protection against both moderate and severe COVID-19 infection. N-Methyl-1-(pyrazin-2-yl)methanamine manufacturer Beijing will strengthen its monitoring of overseas drug market and collect global prices for imported medicines, Friday��s guideline said. N-Methyl-1-(pyrazin-2-yl)methanamine supplier Lilly has denied retaliating against any employees, and no lawsuit has been filed on behalf of Mula. N-Methyl-1-(pyrazin-2-yl)methanamine vendor The entire set of results “strongly support” the Darzalex-Rd combo as a new standard of care for newly diagnosed, transplant-ineligible multiple myeloma patients, Thierry Facon, M.D., an investigator of the MAIA trial, said in a statement. N-Methyl-1-(pyrazin-2-yl)methanamine factory Lilly has denied retaliating against any employees, and no lawsuit has been filed on behalf of Mula.
